Company Executives

$ZLAB Management Team

Name / Title	Age	Compensation	Sex	Social Media

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

7 of 9

stated in the proxy

Average tenure

7.7 years

from year joined

CEO also chairs the board

Yes

Samantha (Ying) Du

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Samantha (Ying) Du Board chair, CEO	61	2014 12 years	Not independent	Research and Development	None stated	Paid as CEO
John David Diekman Lead independent director	83	2017 9 years	Independent	None stated	None stated	$513,614
Richard Brian Gaynor	76	2021 5 years	Independent	None stated	Alkermes plc (NASDAQ)	$465,940
Nisa Bernice Wing-Yu Leung	55	2014 12 years	Independent	None stated	None stated	$448,497
William David Lis	61	2018 8 years	Independent	Audit	None stated	$456,114
Scott William Morrison	68	2021 5 years	Independent	None stated	IDEAYA Biosciences Inc. (NASDAQ), Tarsus Pharmaceuticals, Inc. (NASDAQ), Vera Therapeutics, Inc. (NASDAQ)	$474,989
Leon Oliver Moulder, Jr.	68	2020 6 years	Not independent	Commercial	Dianthus Therapeutics, Inc. (NASDAQ)	$479,739
Michel Pericles Vounatsos	64	2023 3 years	Independent	None stated	Revvity, Inc. (NYSE)	$472,965
Peter Karl Wirth	75	2017 9 years	Independent	None stated	None stated	$482,489

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 28, 2026

Mr. Moulder

One of the members of the Company’s Board of Directors; Chief Executive Officer and Chairman of the Board of Directors of Zenas

Amount not stated

Since January 2025

License agreement under which the Company obtained a license under patents and know-how of Zenas to develop and commercialize products targeting IGF-1R in Greater China; upfront fee paid and additional milestone and royalty payments possible.

With Zenas BioPharma (HK) Limited Open in proxy

Comments

Company Executives

$ZLAB Management Team

Board of Directors

Related-party transactions